Article

Generic Drug Growth Highlights AJPB Week in Review

Author(s):

Lauren Santye, Assistant Editor

Most read articles of the week on The American Journal of Pharmacy Benefits.

Related Videos
5 experts in this video
5 experts in this video
Image credit: Photo18@desing | stock.dobe.com
1 expert is featured in this series.
Related Content
AACR 2025: Continuous Subcutaneous Lenalidomide Shows Promise in Reducing Toxicity in R/R Multiple Myeloma
April 30th 2025

AACR 2025: Continuous Subcutaneous Lenalidomide Shows Promise in Reducing Toxicity in R/R Multiple Myeloma

Alana Hippensteele, Lead Editor
Insights from a Pharmacy Times Peer Exchange: ADC Drug Design and HER2 Ultra-Low Breast Cancer Indiciations
April 29th 2025

Insights from a Pharmacy Times Peer Exchange: ADC Drug Design and HER2 Ultra-Low Breast Cancer Indiciations

Alexandra Gerlach, Associate Editor
Next-generation sequencing | Image Credit: © Supaporn - stock.adobe.com
April 30th 2025

Biomarker Testing Transforms NSCLC Care, But Gaps Persist in Community Settings

Alexandra Gerlach, Associate Editor
The RIVAWAR Trial and ACS Guidelines for LV Thrombus
April 22nd 2025

The RIVAWAR Trial and ACS Guidelines for LV Thrombus

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP Aislinn Antrim, Managing Editor
US FDA logo on smartphone -- Image credit: Luciano Luppa | stock.adobe.com
April 30th 2025

FDA Approves Nipocalimab-Aahu to Treat Patients With Generalized Myasthenia Gravis

Gillian McGovern, Associate Editor
National Stress Awareness Month Is Here
April 30th 2025

National Stress Awareness Month Is Here

Jennifer Gershman, PharmD, CPh, PACS